Table 3 Comparisons of clinical characteristics between Large lobar consolidation and Diffuse bronchiolitis in children who developed to PIBO
Variables | Large lobar consolidation (n = 50) | Diffuse bronchiolitis (n = 18) | p |
|---|---|---|---|
Age (years) | 6.8 (5.5, 8.3) | 3.9 (3, 7.2) | 0.003 |
Sex, male | 25 (50%) | 10 (55.6%) | 0.69 |
Atopic conditions, n (%) | 28 (56%) | 13 (72.2%) | 0.23 |
Family history of atopic disease | 13 (26%) | 5 (27.8%) | 0.88 |
Atopic dermatitis | 10 (20%) | 6 (33.3%) | 0.25 |
Allergic rhinitis | 18 (36%) | 9 (50%) | 0.30 |
Asthma | 5 (10%) | 2 (11.1%) | 0.89 |
Acute lower pulmonary infections stage | |||
Symptoms | |||
Fever | 49 (98%) | 18 (100%) | NA |
Cough | 50(100%) | 18 (100%) | NA |
Wheezing and/or dyspnea | 5 (10.3%) | 7 (38.9%) | 0.006 |
Duration of fever (days) | 10 (8, 12) | 9 (7, 10) | 0.051 |
Laboratory findings | |||
WBC count (1 × 109/L) | 8.5 (6.3, 11.6) | 7.5 (5.9, 10.5) | 0.51 |
CRP (mg/L) | 65 (34, 101) | 19 (11, 37) | < 0.001 |
D-dimer (ng/mL) | 1.9 (0.7, 3.8) | 0.7 (0.2, 1.1) | < 0.001 |
ALT (IU/L) | 38.4 (21, 85.2) | 17 (11, 22) | < 0.001 |
LDH (IU/L) | 615 (385, 1009) | 347 (298, 463) | < 0.01 |
Co-infection, n (%) | 14 (28%) | 9 (50%) | 0.09 |
Adenovirus | 5 (10.0%) | 5 (27.8%) | 0.07 |
Bacteria | 9 (18%) | 4 (22.2%) | 0.69 |
Other virus | 3 (5%) | 2 (11.1%) | 0.48 |
Treatment, n (%) | |||
Non-invasive/ invasive ventilation | 13 (26%) | 6 (33.3%) | 0.55 |
Glucocorticoid | 48 (96%) | 18 (100%) | NA |
Bronchial mucus plug (Bronchoscopy), n (%) | 35 (70%) | 9 (50%) | 0.13 |